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OBJECTIVES We sought to evaluate the safety and efficacy of higher energy synchronized cardioversion in
patients with atrial fibrillation refractory to standard energy direct current (DC) cardioversion.
BACKGROUND Standard external electrical cardioversion fails to restore sinus rhythm in 5% to 30% of
patients with atrial fibrillation.
METHODS Patients with atrial fibrillation who failed to achieve sinus rhythm after at least two attempts
at standard external cardioversion with 360 J were included in the study. Two external
defibrillators, each connected to its own pair of R-2 patches in the anteroposterior position,
were used to deliver a synchronized total of 720 J.
RESULTS Fifty-five patients underwent cardioversion with 720 J. Mean weight was 117 6 23 kg (body
mass index 48.3 6 4.1 kg/m2). Structural heart disease was present in 76% of patients. Mean
left ventricular ejection fraction was 45 6 12%. Atrial fibrillation was present for over three
months in 55% of the patients. Sinus rhythm was achieved in 46 (84%) of the 55 patients. No
major complications were observed. No patient developed hemodynamic compromise and no
documented cerebrovascular accident occurred within one month after cardioversion. Of the
46 successful cardioversions, 18 patients (39%) remained in sinus rhythm over a mean
follow-up of 2.1 months.
CONCLUSIONS External higher energy cardioversion is effective in restoring sinus rhythm in patients with
atrial fibrillation refractory to standard energy DC cardioversion. This method is safe and
does not result in clinical evidence of myocardial impairment. It may be a useful alternative
to internal cardioversion because it could be done within the same setting of the failed
standard cardioversion and obviates the need to withhold protective anticoagulation for
internal cardioversion. (J Am Coll Cardiol 1999;34:2031–4) © 1999 by the American
College of Cardiology
Direct current (DC) cardioversion, first reported by Lown
et al. (1), remains the most effective approach to convert
atrial fibrillation to sinus rhythm. However, external cardio-
version using currently available maximal energies is inef-
fective for 5% to 30% of patients (2–4). Multiple factors
contribute to failure, including duration of atrial fibrillation,
position and size of shock electrodes (5) and patient body
habitus, which influences transthoracic impedance (6).
High impedance can decrease the effective energy delivered
to the atria in large-bodied patients. Patients in whom
standard external cardioversion fails often receive treatment
aimed at rate control alone or an attempt at internal
cardioversion (4). Although internal cardioversion has been
effective when atrial fibrillation is refractory to external
cardioversion, it requires invasive placement of right atrial,
coronary sinus or pulmonary artery defibrillation electrodes.
This can be problematic because of the need for periproce-
dural discontinuation of anticoagulation. Such discontinu-
ation may increase the risk of left atrial clot formation and
systemic embolization.
We report a novel method of delivering synchronized,
higher energy DC external shocks for cardioversion of atrial
fibrillation refractory to conventional external cardioversion
energies. This method has essentially eliminated the need
for invasive internal cardioversion at our institution.
METHODS
Patients undergoing routine cardioversion of atrial fibrilla-
tion in our electrophysiology laboratory were included in
this report if they did not achieve any beats of sinus rhythm
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after standard external DC cardioversion with maximal
energies of 360 J in the anteroposterior patch positions.
Repeat cardioversion with 360 J was attempted before
proceeding to the high energy cardioversion protocol. In all
patients, therefore, cardioversion of atrial fibrillation failed
with at least two attempts at 360 J using our standard
approach.
Written, informed consent was obtained from all patients
before the procedures. Two external defibrillators (PD
1200, Zoll Medical Corp., Woburn, Massachusetts) were
each connected to a separate pair of R-2 patches (Stat-padz,
Zoll Medical Corp., Burlington, Massachusetts). Each pair
of patches was placed in the anteroposterior position of the
patient’s chest. The two anterior patches were placed next to
each other. Similarly, the two posterior patches were placed
adjacent to each other. A five-electrode electrocardiographic
(ECG) signal was split using a custom-made signal splitter
and routed to both defibrillator ECG inputs. This signal
served as the synchronization input for both defibrillators.
The two defibrillators used for these procedures were
visually checked to ensure that both synchronized on the
same upstroke or downstroke portion of the ECG signal.
The same ECG lead and gain were used on both defibril-
lators. Sedation was achieved with methohexital
(;0.6 mg/kg body weight initial dose). The energy delivery
buttons on both defibrillators were pushed simultaneously
by a single operator, resulting in synchronized shocks
delivering a total of 720 J. “Successful cardioversion” was
defined as termination of atrial fibrillation with achievement
of sinus or junctional rhythm.
Statistical analysis. Results are reported as the mean
value 6 SD with 95% confidence limits, unless reported
otherwise.
RESULTS
Between June 1996 and April 1999, 55 patients underwent
cardioversion with 720-J shocks. Patient characteristics are
summarized in Table 1. The mean left ventricular ejection
fraction was 45 6 12%, as estimated by echocardiography
or radionuclide ventriculography. The left atrium was nor-
mal in 10 patients (18.1%), mildly enlarged in 22 (40.1%),
moderately enlarged in 12 (21.8%) and severely enlarged in
2 (3.6%). Nine patients did not have left atrial dimensions
available. Thirteen patients (23.6%) did not have evidence
of structural heart disease. Coronary artery disease was
present in 12 (21.8%), left ventricular hypertrophy in 13
(23.6%), valvular heart disease in 7 (12.7%) and primary
myocardial disease (dilated cardiomyopathy, right ventricu-
lar dysfunction) in 12 (21.8%) patients.
Atrial fibrillation was present for .1 year before the
cardioversion in 12 (22%), three months to one year in 18
(33%), one month to three months in 13 (24%) and ,1
month in 10 (18%) patients. In two patients, the duration
could not be ascertained. All patients were anticoagulated.
Ninety percent were on Coumadin (warfarin sodium) with
an international normalized ratio (INR) $2; 10% were on
heparin because of new-onset atrial fibrillation or inade-
quate anticoagulation with Coumadin.
Forty-eight patients (87%) were taking antiarrhythmic
medication at the time of cardioversion. Antiarrhythmic
medications included amiodarone (41%), sotalol (20%),
flecainide (20%), procainamide (4%) and disopyramide
(2%). Digoxin, calcium channel blockers and beta-blockers
were used for rate control in 63%, 20% and 38% of the
patients, respectively.
Eleven patients received more than one attempted 720-J
shock at the same session—in eight patients because the
720-J shocks failed to terminate atrial fibrillation and in one
patient because of recurrence of atrial fibrillation within
5 min of the initial 720-J shock. In two patients a repeat
attempt was performed because the initial attempt triggered
only one of the two defibrillators. This failure to trigger
both defibrillators was due to inadequate application of
simultaneous manual pressure on the two defibrillator
switches.
Sinus rhythm was achieved in 46 (84%) of the 55 patients
(95% confidence interval 74% to 93%). Chart review or
telephone follow-up was adequate in 53 of the 55 patients to
determine whether there was recurrence of atrial fibrillation.
Of the 46 patients with successful cardioversion, atrial
fibrillation recurred in 28 (61%). Recurrence was within
24 h in 8 patients, 1 to 30 days in 13 patients, 30 to 90 days
in 4 patients and .90 days in 1 patient. Eighteen patients
(39%) remained in sinus rhythm during a mean follow-up
period of 2.1 6 1.8 months. One patient with successful
cardioversion was lost to follow-up. Of the 28 patients with
recurrent atrial fibrillation, four patients underwent a second
cardioversion and three patients underwent two further
cardioversions using the 720-J shock at a later date, all of
which were successful in achieving sinus rhythm.
No patient developed hemodynamic compromise or con-
gestive heart failure. One patient developed transient bra-
dycardia without sequealae. In another patient (taking
amiodarone) cardioversion failed and transient right bundle
branch block (RBBB) developed, and, later that day, she
Abbreviations and Acronyms
DC 5 direct current
ECG 5 electrocardiogram
RBBB 5 right bundle branch block
Table 1. Patient Characteristics (n 5 55)
Age (yrs) 61 (range 36–83)
Males (%) 47 (85%)
Height (cm) 177.6 6 8.0
Weight (kg) 117.6 6 22.7
Body mass index (kg/m2) 48.3 6 4.1
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developed sinus bradycardia–induced torsade de pointes.
She underwent pacemaker placement and the remainder of
her hospital course was uneventful. Interestingly, she
weighed 71 kg and was the lightest of the patients included
in this report. There was no documented stroke or transient
ischemic cerebral event reported within one month after
cardioversion. No patient had any recollection of receiving a
shock during cardioversion or reported any undue pain or
discomfort related to the procedure. Skin injury was limited
to the usual irritation around the patches observed after
cardioversion with our standard approaches.
DISCUSSION
Our study shows that higher energy cardioversion is an
effective and safe option to restore sinus rhythm in patients
refractory to standard energy external cardioversion. Our
success rate, 84% conversion of atrial fibrillation, was similar
to those of previous preliminary reports (7,8).
Potential for myocardial damage. It has been reported
that excessive energy delivery with cardioversion attempts
can induce myocardial damage (9), manifested as gross and
histologic abnormalities along with elevation of serum
cardiac enzymes. Most of the reports in the published data
that showed significant myocardial damage were done in
open-chest animals and used shocks delivered in sinus
rhythm. It has been postulated that the mechanism of such
damage is mediated through generation of free radicals,
which are toxic to the myocardium (10), and is related to the
shock energy used. Other studies suggested that the total
electrical energy used for cardioversion does not affect the
degree of mechanical dysfunction of either the left atrium or
the left atrial appendage after conversion to sinus rhythm
(11). In the present study, cardiac enzymes were not
routinely obtained after the procedure. However, other
investigators have reported no significant increase in creat-
ine kinase, MB fraction after cardioversion with 720-J
shocks. (8) In our study, none of the patients developed
significant hemodynamic compromise or high grade atrio-
ventricular block after the procedure.
Selection of patients. In all our patients cardioversion
failed at maximal energies available with a standard external
defibrillator. The efficacy of defibrillation is in part related to
transthoracic impedance (6). Increased transthoracic imped-
ance is related to body habitus. Thus, large patients may
require the application of a higher level of external energy to
achieve an adequate but not excessive amount of cardiac
current flow for effective cardioversion. Given the size of our
patients, as shown by the mean body mass index (Table 1),
failure of standard energy cardioversion was most likely due
to increased transthoracic impedance, resulting in insuffi-
cient current reaching the myocardium.
Comparison to internal cardioversion. Internal cardio-
version has been effective in restoring sinus rhythm in 71%
to 91% of patients with atrial fibrillation refractory to
external cardioversion (4, 12, 13). However, internal cardio-
version requires invasive catheterization for placement of
right atrial, coronary sinus or pulmonary artery defibrillation
electrodes. This may be problematic because of the need to
stop or reduce anticoagulation around the time of the
procedure, potentially increasing the risk of embolic stroke.
Attempting higher energy external cardioversion first seems
justifiable in view of the similar efficacy and the absence of
clinical complications in our study.
Mechanism of improved cardioversion. It is interesting to
speculate on the potential mechanism by which the use of
two defibrillators, as reported here, could improve defibril-
lation success. In our setup, the defibrillation system capac-
itance is doubled, whereas the peak voltage of each defibril-
lator is the same. The use of two sets of skin electrodes
doubles the surface area of the electrodes and reduces overall
transthoracic impedance. We did not measure this imped-
ance and thus could not quantify this decrease. Although
the peak voltage delivered by the defibrillators does not
increase, it is likely that voltage gradients in portions of the
heart increase due to the greater current delivery in this
setup. Lack of success in large patients using a single
defibrillator is likely due to a low voltage gradient in at least
some portions of the atria. The use of two sets of patches
may improve the voltage gradients in those areas owing to
the position of the second set of patches increasing the
spread of the shock field in combination with the increased
current flow.
Potential problems. The one patient who developed tran-
sient RBBB was the lightest in weight of our patient group.
Thus, we would advocate caution in applying this technique
to patients of normal or light weight, as the additional
delivered energy may have a greater propensity to cause
harm in such patients. The potential for damage to the
defibrillators should also be considered. In our study, the
defibrillator skin electrodes were not in contact with each
other. However, if the electrodes were to touch each other
and provide a low impedance path for current to flow from
one defibrillator to another, there is some potential for
causing harm to the defibrillators if the defibrillators did not
synchronize appropriately. In our patient group, we did not
observe any harm to the defibrillators, as evidenced by the
continued normal operation of the defibrillators at subse-
quent use and testing.
Future directions. External defibrillators with biphasic
waveforms are becoming available for clinical use. The
biphasic waveform has been reported to be more effective
than the monophasic waveform for cardioverting ventricular
tachyarrhythmias (14–16). Thus, it would be reasonable to
hypothesize that biphasic waveforms may be more effica-
cious in external cardioversion of atrial fibrillation as well.
The energy requirement necessary with a biphasic waveform
remains to be determined.
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Study limitations and conclusions. Higher energy syn-
chronized external DC cardioversion of atrial fibrillation
was an effective and safe method for restoring sinus rhythm
in our patients who were refractory to standard energy
attempts. Because our group included predominantly pa-
tients of large body habitus, this procedure can only be
recommended in patients with similar body weights in
whom conventional external cardioversion has failed. Cau-
tion must be used in smaller patients in whom cardioversion
has failed. Failure in these cases may not be related to
inadequate cardiac current flow, and the risk of myocardial
injury may be greater.
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